ARTICLE | Company News
Takeda sales and marketing update
June 28, 2010 7:00 AM UTC
Takeda's Takeda Pharmaceuticals North America Inc. subsidiary launched ACTOplus met XR extended-release pioglitazone/metformin tablets in the U.S. to treat Type II diabetes. The once-daily fixed-dose...